In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Nurix Therapeutics Inc’s stock clocked out at $19.01, down -0.31% from its previous closing price of $19.07. In other words, the price has decreased by -$0.31 from its previous closing price. On the day, 2.22 million shares were traded. NRIX stock price reached its highest trading level at $19.59 during the session, while it also had its lowest trading level at $18.54.
Ratios:
To gain a deeper understanding of NRIX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.14.
On October 21, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $24.
On March 17, 2025, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $16.Leerink Partners initiated its Market Perform rating on March 17, 2025, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Ring Christine sold 37,600 shares for $17.07 per share. The transaction valued at 641,697 led to the insider holds 50,897 shares of the business.
CHRISTINE RING bought 37,600 shares of NRIX for $630,176 on Nov 24 ’25. On Nov 03 ’25, another insider, van Houte Hans, who serves as the Chief Financial Officer of the company, sold 6,284 shares for $12.56 each. As a result, the insider received 78,931 and left with 37,592 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1927029120 and an Enterprise Value of 1089211136. For the stock, the TTM Price-to-Sale (P/S) ratio is 23.03 while its Price-to-Book (P/B) ratio in mrq is 3.93. Its current Enterprise Value per Revenue stands at 13.015 whereas that against EBITDA is -4.2.
Stock Price History:
The Beta on a monthly basis for NRIX is 1.93, which has changed by -0.09962231 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, NRIX has reached a high of $22.50, while it has fallen to a 52-week low of $8.18. The 50-Day Moving Average of the stock is 39.10%, while the 200-Day Moving Average is calculated to be 63.26%.
Shares Statistics:
It appears that NRIX traded 1.69M shares on average per day over the past three months and 2238860 shares per day over the past ten days. A total of 101.37M shares are outstanding, with a floating share count of 99.81M. Insiders hold about 1.53% of the company’s shares, while institutions hold 82.45% stake in the company. Shares short for NRIX as of 1764288000 were 14487622 with a Short Ratio of 8.58, compared to 1761868800 on 13118235. Therefore, it implies a Short% of Shares Outstanding of 14487622 and a Short% of Float of 16.1.
Earnings Estimates
Its stock is currently analyzed by 12.0 different market analysts. The consensus estimate for the next quarter is -$0.83, with high estimates of -$0.61 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$2.48 and -$3.39 for the fiscal current year, implying an average EPS of -$3.1. EPS for the following year is -$3.41, with 13.0 analysts recommending between -$2.13 and -$4.46.
Revenue Estimates
For the next quarter, 16 analysts are estimating revenue of $16.72M. There is a high estimate of $22.5M for the next quarter, whereas the lowest estimate is $13.8M.
A total of 17 analysts have provided revenue estimates for NRIX’s current fiscal year. The highest revenue estimate was $108.78M, while the lowest revenue estimate was $70.4M, resulting in an average revenue estimate of $85.23M. In the same quarter a year ago, actual revenue was $54.55M
